Understanding how EWS-FLI1 oncogene affects cell growth in Ewing sarcoma
Mechanisms underlying USP1-mediated bypass of EWS-FLI1 oncogene-induced replication stress in Ewing sarcoma
This study is looking at how a specific gene in Ewing sarcoma cells helps them grow uncontrollably by avoiding the usual ways that cells fix their damaged DNA, and it hopes to find new treatment options that could help patients with this type of bone cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10894628 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the EWS-FLI1 oncogene causes replication stress in Ewing sarcoma, a type of bone cancer. It focuses on how cancer cells bypass the normal DNA damage response that would typically stop their growth, leading to uncontrolled cell proliferation. By studying the role of the USP1 protein, which is found to be overexpressed in Ewing sarcoma cells, the research aims to uncover new therapeutic targets that could improve treatment outcomes for patients. The approach combines basic science with potential clinical applications, providing insights into the disease's progression.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with Ewing sarcoma, particularly those with high levels of the EWS-FLI1 oncogene.
Not a fit: Patients with other types of cancers or those without the EWS-FLI1 oncogene may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that specifically target the mechanisms of Ewing sarcoma, potentially improving survival rates.
How similar studies have performed: While the specific mechanisms of USP1 in Ewing sarcoma are being explored, similar research has shown promise in understanding oncogene-induced replication stress in other cancers.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Ghosal, Gargi — University of Nebraska Medical Center
- Study coordinator: Ghosal, Gargi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.